TG Therapeutics TGTX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's total cost of revenue?
- TG Therapeutics (TGTX) reported total cost of revenue of $33.51M in Q1 2026.
- How has TG Therapeutics's total cost of revenue changed year-over-year?
- TG Therapeutics's total cost of revenue increased by 115.6% year-over-year, from $15.54M to $33.51M.
- What is the long-term trend for TG Therapeutics's total cost of revenue?
- Over 2 years (2023 to 2025), TG Therapeutics's total cost of revenue has grown at a 167.0% compound annual growth rate (CAGR), from $14.13M to $100.71M.
- What does total cost of revenue mean?
- The direct costs incurred to produce the products or services sold by the company.
- How do you interpret total cost of revenue?
- An increase relative to revenue suggests margin compression, while a decrease relative to revenue indicates improved production efficiency.
- How does total cost of revenue compare across companies?
- Commonly referred to as Cost of Goods Sold (COGS) in manufacturing or Cost of Services in service-based firms.